silybin has been researched along with Infarction, Middle Cerebral Artery in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, Y; Guo, YY; Li, YJ; Liu, SB; Sun, T; Wang, M; Wu, YM; Yang, L; Zhang, HN; Zhang, K; Zhao, MG | 1 |
Chen, L; Dong, L; Li, Y; Liu, Z; Qiao, H; Wang, C; Wang, L; Wang, Z; Xing, Y; Zhang, X; Zhu, C | 1 |
2 other study(ies) available for silybin and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Silibinin Prevents Autophagic Cell Death upon Oxidative Stress in Cortical Neurons and Cerebral Ischemia-Reperfusion Injury.
Topics: Animals; Apoptosis; Autophagy; Brain Ischemia; Cell Survival; Cells, Cultured; Cerebral Cortex; Hydrogen Peroxide; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Neurons; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Silybin; Silymarin | 2016 |
Protection by silibinin against experimental ischemic stroke: up-regulated pAkt, pmTOR, HIF-1α and Bcl-2, down-regulated Bax, NF-κB expression.
Topics: Animals; bcl-2-Associated X Protein; Brain; Brain Ischemia; Down-Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Male; Nerve Tissue Proteins; Neuroprotective Agents; NF-kappa B; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Silybin; Silymarin; Stroke; TOR Serine-Threonine Kinases; Treatment Outcome; Up-Regulation | 2012 |